share

Myo-Inositol, 1-o-(4-Methoxyphenyl)Methyl-2,4,5,6-Tetrakis-o-(Phenylmethyl)- CAS NO 140887-09-8


Unit Price:

CAS No.:140887-09-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Myo-Inositol, 1-o-(4-Methoxyphenyl)Methyl-2,4,5,6-Tetrakis-o-(Phenylmethyl)- is a protected derivative of myo-inositol, a key cyclitol with significant biological relevance. This compound is a crucial advanced pharmaceutical intermediate used in the synthesis of complex molecules, particularly inositol phosphate analogs and other bioactive compounds. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing novel therapeutics and biochemical tools.

Application

  • Pharmaceutical Intermediate: A key building block for the synthesis of inositol phosphate derivatives and analogs with potential therapeutic applications.
  • Biochemical Research: Used in the study of cellular signaling pathways, particularly those involving phosphatidylinositols.
  • Glycoconjugate Synthesis: Serves as a protected scaffold for the preparation of complex carbohydrates and glycoconjugates.
  • Medicinal Chemistry: Employed in the development of enzyme inhibitors and receptor ligands targeting inositol-related pathways.
  • Chemical Biology Probes: Used to create labeled or modified inositol derivatives for tracking and mechanistic studies.
  • Fine Chemical Production: An intermediate in the multi-step synthesis of high-value specialty chemicals.

Basic Information

Product Name Myo-Inositol, 1-o-(4-Methoxyphenyl)Methyl-2,4,5,6-Tetrakis-o-(Phenylmethyl)-
CAS No. 140887-09-8
Molecular Formula C47H52O11
Molecular Weight 792.91 g/mol
Synonyms 1-O-(4-Methoxybenzyl)-2,4,5,6-tetra-O-benzyl-myo-inositol; 1-O-(p-Methoxybenzyl)-2,4,5,6-tetra-O-benzyl-myo-inositol; 1-(4-Methoxybenzyl)-2,4,5,6-tetrabenzyl-myo-inositol; myo-Inositol, 1-O-[(4-methoxyphenyl)methyl]-2,4,5,6-tetrakis-O-(phenylmethyl)-; Protected myo-Inositol derivative; Tetrabenzyl Monomethoxybenzyl Inositol; Inositol benzyl ether derivative
EINECS Contact for details

Quality Control

Our Myo-Inositol derivative is produced under strict quality control protocols suitable for research and fine chemical synthesis. We employ advanced analytical techniques including HPLC, NMR, and mass spectrometry to ensure identity, purity, and batch-to-batch consistency. Certificates of Analysis (COA) detailing all relevant specifications are provided with each shipment to support your quality assurance processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 95.0%
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.